Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 8/20 | 0.39 |
| ▸ | ADH1C | P00326 | 5/20 | 0.39 |
| ▸ | PHGDH | O43175 | 2/20 | 0.34 |
| ▸ | ADH1B | P00325 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ADH4 | P08319 | 1/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20228495 | 0.97 | ADH1A (0.35) | ADH1AADH1CPHGDHADH1BFAAH | |
| SCHEMBL19968446 | 0.94 | ADH1C (0.31) | ADH1AADH1C | |
| SCHEMBL21150311 | 0.81 | ADH1A (0.32) | ADH1AADH1C | |
| SCHEMBL28226498 | 0.78 | PHGDH (0.37) | ADH1AADH1CPHGDHADH1BFAAH | |
| SCHEMBL11626082 | 0.78 | PHGDH (0.37) | ADH1AADH1CPHGDHADH1BFAAH | |
| SCHEMBL810840 | 0.78 | PHGDH (0.37) | ADH1AADH1CPHGDHADH1BFAAH | |
| SCHEMBL29234274 | 0.78 | CYP1A2 (0.34) | ADH1AADH1CCYP1A2 | |
| SCHEMBL11954802 | 0.77 | ADH1A (0.39) | ADH1AADH1CPHGDHADH1BFAAH | |
| Hydrochloric Acid SCHEMBL7267471 | 0.76 | ADH1A (0.34) | ADH1AADH1CPHGDHADH1BFAAH | |
| SCHEMBL25274904 | 0.74 | PHGDH (0.33) | ADH1AADH1CPHGDHFAAHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026537-A1 | METHOD FOR FORMING METAL OXIDE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-05-06 | — | — | US | disclosed |
| US-10357764-B2 | Phosphacycle compound and process for production thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-23 | — | — | US | disclosed |
| US-10207262-B2 | Chromium complex and catalyst therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-02-19 | — | — | US | disclosed |
| US-20180071725-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-03-15 | — | — | US | disclosed |
| US-9809602-B2 | Compounds for treating viral infections | INSTITUT PASTEUR KOREA (KR) | 2017-11-07 | — | — | US | disclosed |
| US-20170044181-A1 | COMPOUNDS FOR TREATING VIRAL INFECTIONS | INSTITUT PASTEUR KOREA (KR) | 2017-02-16 | — | — | US | disclosed |
| EP-2169018-B1 | Ink composition and inkjet recording method | FUJIFILM CORP (JP) | 2012-01-18 | — | — | EP | disclosed |
| EP-2169022-B1 | Ink composition and inkjet recording method | FUJIFILM CORP (JP) | 2011-11-16 | — | — | EP | disclosed |
| US-7900558-B2 | Radiation-curable polymerizable composition, ink composition, inkjet recording method, printed material, planographic printing plate, and method for forming planographic printing plate | FUJIFILM CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| CN-1290926-C | Lactic acid polymer composition and molded object thereof | NEW JAPAN CHEM CO LTD (JP) | 2006-12-20 | — | — | CN | disclosed |
| EP-1454958-B1 | LACTIC ACID POLYMER COMPOSITION AND MOLDED OBJECT THEREOF | NEW JAPAN CHEM CO LTD (JP) | 2006-10-04 | — | — | EP | disclosed |
| CN-1585802-A | Lactic acid polymer composition and molded object thereof | NEW JAPAN CHEM CO LTD (JP) | 2005-02-23 | — | — | CN | disclosed |
| US-20050001349-A1 | Lactic acid polymer composition and molded object thereof | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-1454958-A1 | LACTIC ACID POLYMER COMPOSITION AND MOLDED OBJECT THEREOF | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2004-09-08 | — | — | EP | disclosed |
| US-5973076-A | MOLDING; CONTROLLING TEMPERATURE IN PRESENCE OF AN AMIDE COMPOUND | NEW JAPAN CHEMICAL CO., LTD. (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0776933-B1 | Polybutene-1 resin composition and a method of accelerating the crystal transformation | NEW JAPAN CHEM CO LTD (JP) | 1999-08-04 | — | — | EP | disclosed |
| EP-0776933-A1 | Polybutene-1 resin composition and a method of accelerating the crystal transformation | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1997-06-04 | — | — | EP | disclosed |
| EP-0001290-A1 | Substituted 2,3-dihydrobenz-(d)-isothiazole-1,1-dioxides and 2,3-dihydronaphtho-(1,8-de)-1,2-thiazine-1,1-dioxides | POLAROID CORPORATION (US) | 1979-04-04 | — | — | EP | disclosed |
| US-4137261-A | Manufacture of N-vinyl-N-alkyl-carbamic acid chlorides | BASF AKTIENGESELLSCHAFT (DE) | 1979-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | ADH1A 3029/4885ADH1C 2213/4885PHGDH 4059/4885 |
| US-20180071725-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | OXER1, LIG1, PICALM | ADH1A 3067/4885ADH1C 2335/4885PHGDH 4066/4885 |
| US-10357764-B2 | Phosphacycle compound and process for production thereof | OXER1, PPIP5K2, IP6K1 | ADH1A 3277/4885ADH1C 2869/4885PHGDH 1409/4885 |
| US-10207262-B2 | Chromium complex and catalyst therefrom | OXER1, LIG1, PICALM | ADH1A 3067/4885ADH1C 2335/4885PHGDH 4066/4885 |
| US-20170044181-A1 | COMPOUNDS FOR TREATING VIRAL INFECTIONS | HAVCR2, MAVS, EIF2AK2 | ADH1A 920/4885ADH1C 1153/4885PHGDH 1168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.